Robert L. Little
2009
In 2009, Robert L. Little earned a total compensation of $412K as Vice President and Chief Commercial Officer at Halozyme Therapeutics, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $5,355 |
|---|---|
| Option Awards | $70,378 |
| Salary | $334,000 |
| Other | $2,249 |
| Total | $411,982 |
Little received $334K in salary, accounting for 81% of the total pay in 2009.
Little also received $5.4K in non-equity incentive plan, $70.4K in option awards and $2.2K in other compensation.
Rankings
In 2009, Robert L. Little's compensation ranked 7,465th out of 9,885 executives tracked by ExecPay. In other words, Little earned more than 24.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,465 out of 9,885 | 25th |
Division Manufacturing | 2,782 out of 3,690 | 25th |
Major group Chemicals And Allied Products | 628 out of 866 | 28th |
Industry group Drugs | 445 out of 638 | 30th |
Industry Biological Products, Except Diagnostic Substances | 81 out of 133 | 39th |
Source: SEC filing on March 24, 2011.
Little's colleagues
We found eight more compensation records of executives who worked with Robert L. Little at Halozyme Therapeutics in 2009.
2009
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2009
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2009
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2009
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2009
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2009
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2009
David Ramsay
Halozyme Therapeutics
Vice President Corporate Development
2009
Michael LaBarre
Halozyme Therapeutics